Generation of an inducible dCas9-SAM human PSC line for endogenous gene activation.
Saved in:
| Title: | Generation of an inducible dCas9-SAM human PSC line for endogenous gene activation. |
|---|---|
| Authors: | Petazzi P; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain., Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain., Roca-Ho H; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain., Castaño J; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain., Alvarez N; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain., Forrester LM; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom., Sevilla A; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Institute of Biomedicine, University of Barcelona (IBUB), Barcelona, Spain., Fidanza A; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom., Menendez P; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, Casanova 143, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2024 Nov 29; Vol. 12, pp. 1484955. Date of Electronic Publication: 2024 Nov 29 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39676795 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Generation of an inducible dCas9-SAM human PSC line for endogenous gene activation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Petazzi+P%22">Petazzi P</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gutierrez-Agüera+F%22">Gutierrez-Agüera F</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Roca-Ho+H%22">Roca-Ho H</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castaño+J%22">Castaño J</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bueno+C%22">Bueno C</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez+N%22">Alvarez N</searchLink>; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Forrester+LM%22">Forrester LM</searchLink>; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sevilla+A%22">Sevilla A</searchLink>; Department of Cell Biology, Physiology, and Immunology, Faculty of Biology, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Institute of Biomedicine, University of Barcelona (IBUB), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fidanza+A%22">Fidanza A</searchLink>; Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Menendez+P%22">Menendez P</searchLink>; Josep Carreras Leukemia Research Institute, Campus Clinic-UB, Casanova 143, Barcelona, Spain.; Spanish Network for Advanced Cell Therapies (TERAV), Carlos III Health Institute, Barcelona, Spain.; Spanish Cancer Network (CIBERONC), Carlos III Health Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, Casanova 143, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101630250%22">Frontiers in cell and developmental biology</searchLink> [Front Cell Dev Biol] 2024 Nov 29; Vol. 12, pp. 1484955. <i>Date of Electronic Publication: </i>2024 Nov 29 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101630250 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-634X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296634X%22">2296634X </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Dev Biol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39676795 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fcell.2024.1484955 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1484955 Titles: – TitleFull: Generation of an inducible dCas9-SAM human PSC line for endogenous gene activation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Petazzi P – PersonEntity: Name: NameFull: Gutierrez-Agüera F – PersonEntity: Name: NameFull: Roca-Ho H – PersonEntity: Name: NameFull: Castaño J – PersonEntity: Name: NameFull: Bueno C – PersonEntity: Name: NameFull: Alvarez N – PersonEntity: Name: NameFull: Forrester LM – PersonEntity: Name: NameFull: Sevilla A – PersonEntity: Name: NameFull: Fidanza A – PersonEntity: Name: NameFull: Menendez P IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 11 Text: 2024 Nov 29 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2296-634X Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in cell and developmental biology Type: main |
| ResultId | 1 |